| scholarly article | Q13442814 |
| P50 | author | Peter Bartenstein | Q101474031 |
| Hans-Georg Buchholz | Q102031615 | ||
| P2093 | author name string | Gerhard Gründer | |
| Mathias Schreckenberger | |||
| Christian Landvogt | |||
| Igor Yakushev | |||
| Christoph Fehr | |||
| Thomas F Dielentheis | |||
| Reinhard Urban | |||
| Nina Hohmann | |||
| Natalie Chechko | |||
| P2860 | cites work | From blue states to up states: a regional view of NMDA-ethanol interactions | Q46347458 |
| Tiagabine reduces ethanol reward in C57BL/6 mice under acute and chronic administration regimens | Q46376318 | ||
| Developmental expression of GABA transporter-1 and 3 during formation of the GABAergic synapses in the mouse cerebellar cortex | Q46604333 | ||
| Functional GABA uptake at inhibitory synapses in CA1 of chronically epileptic rats | Q46696668 | ||
| Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine | Q48128619 | ||
| Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. | Q48329536 | ||
| Applications of random field theory to functional connectivity | Q48366728 | ||
| The relationship between global and local changes in PET scans | Q48940829 | ||
| Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists | Q48988021 | ||
| Tiagabine: absence of kinetic or dynamic interactions with ethanol | Q49067061 | ||
| Reproducibility of cerebral glucose metabolic measurements in resting human subjects. | Q51186529 | ||
| GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. | Q51381890 | ||
| Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study. | Q51409779 | ||
| The new antiepileptic drugs: clinical applications. | Q52003846 | ||
| Vigabatrin | Q70576438 | ||
| [3H]tiagabine binding to GABA uptake sites in human brain | Q73372705 | ||
| Separation and quantitation of the S-(+)-enantiomer in the bulk drug tiagabine x HCl by chiral high-performance-liquid chromatography using a Chiralcel-OD column | Q74303341 | ||
| Addiction, dopamine, and the molecular mechanisms of memory | Q28142501 | ||
| The cognitive neuroscience of sustained attention: where top-down meets bottom-up | Q28187205 | ||
| Development of GABAergic neurons and their transporter in human temporal cortex | Q28211262 | ||
| Neural correlates of perceptual rivalry in the human brain | Q28274142 | ||
| A pharmacologic strategy for the treatment of nicotine addiction | Q28569945 | ||
| The neural basis of addiction: a pathology of motivation and choice | Q29615901 | ||
| Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex | Q29619998 | ||
| Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. | Q30790135 | ||
| Ethanol actions on multiple ion channels: which are important? | Q33767770 | ||
| Basic mechanisms of gabitril (tiagabine) and future potential developments | Q33804496 | ||
| Distribution of mRNA for the GABA transporter GAT-1 in the rat brain: evidence that GABA uptake is not limited to presynaptic neurons | Q33879475 | ||
| GABA systems, benzodiazepines, and substance dependence | Q34186581 | ||
| The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans | Q34326583 | ||
| Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. | Q34440513 | ||
| Anxiety and affective style: role of prefrontal cortex and amygdala | Q34500637 | ||
| New anticonvulsants: a review of applications for the management of substance abuse disorders | Q35083318 | ||
| Therapeutic drug monitoring of the newer antiepileptic drugs | Q35135903 | ||
| Ethanol regulation of gamma-aminobutyric acid A receptors: genomic and nongenomic mechanisms | Q35697046 | ||
| More attention must be paid: the neurobiology of attentional effort | Q36418831 | ||
| Acute alcohol effects on neuronal and attentional processing: striatal reward system and inhibitory sensory interactions under acute ethanol challenge | Q39681875 | ||
| Regulation of gamma-aminobutyric acid synthesis in the brain | Q40868545 | ||
| Comparing functional (PET) images: the assessment of significant change | Q41187707 | ||
| Presynaptic mu and delta opioid receptor modulation of GABAA IPSCs in the rat globus pallidus in vitro | Q42473341 | ||
| Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression | Q42475553 | ||
| A novel strategy for the treatment of cocaine addiction | Q42540010 | ||
| Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats | Q44059488 | ||
| Ventral tegmental area region governs GABA(B) receptor modulation of ethanol-stimulated activity in mice. | Q44194866 | ||
| Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine | Q44396483 | ||
| Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. | Q44600287 | ||
| Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study | Q44654861 | ||
| Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. | Q44682260 | ||
| Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans | Q45068077 | ||
| A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. | Q45282179 | ||
| Plasticity of reward neurocircuitry and the 'dark side' of drug addiction | Q46177203 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 975-983 | |
| P577 | publication date | 2007-01-30 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Tiagabine does not attenuate alcohol-induced activation of the human reward system | |
| P478 | volume | 191 |
| Q46061243 | An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects |
| Q34472695 | Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders |
| Q37087286 | Attenuation of the stimulant response to ethanol is associated with enhanced ataxia for a GABA, but not a GABA, receptor agonist |
| Q35061649 | Ethanol, not detectably metabolized in brain, significantly reduces brain metabolism, probably via action at specific GABA(A) receptors and has measureable metabolic effects at very low concentrations |
| Q28727692 | Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study |
| Q36741866 | Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development? |
Search more.